Northeast Securities: Innovation and R&D Driving Earnings; Focus on the Innovative Drug Sector

Improvements on the funding side and expanding demand on the R&D front are converging, positioning CXOs—key enablers in the innovative‑drug value chain—as poised to benefit first from the resumption of R&D spending and the advancement of clinical programs.

Zhitong FinanceJul 16 02:25 ET

Accelerated partnerships and influx of industry giants propel AI-driven drug discovery into commercial fast lane

A Goldman Sachs research report indicates that AI can shorten drug time-to-market by approximately 20% to 25%, reduce the R&D process by about three years, and potentially lower overall development costs by roughly 25% to 30%.

Zhitong FinanceJul 15 19:08 ET

Junshi Biosciences rose after announcing that Junmikang has been included in the 2026 edition of the National Essential Medicines List.

Junshi Biosciences (01877.HK) rose more than 5%. As of the time of writing, it was up 5.44% at HK$19.53, with a trading volume of HK$44.2619 million.

Zhitong FinanceJul 9 22:23 ET

Junshi Biosciences Sets H Share Register Closure Ahead of July EGM

TipRanksJul 8 09:07 ET

Moving Beyond 'Blind Men Feeling an Elephant': How Two National Pillars Are Joining Forces to Redefine the Paradigm of Innovative Drug R&D | Vital China Shanghai Field Study

① A group of major scientific facilities is transitioning from 'research instruments' into 'catalysts for industrial development,' continuously strengthening the foundational capacity of Shanghai as an international center for science and innovation and providing fundamental scientific support for fostering new quality productive forces. ② In 2025, Shanghai’s gross domestic expenditure on R&D (GERD) is expected to reach approximately 4.5% of GDP, **of which around 12% will be allocated to basic research.**

cls.cnJul 8 06:44 ET

Hong Kong Market Close | Major Indices Diverge as AI Hardware Sector Faces Pullback from Recent Highs

① What are the key domestic and external triggers behind the sharp pullback in Hong Kong-listed technology hardware, memory chip, and optical communications sectors? ② Against a backdrop of weak market performance, why have gold stocks strengthened?

cls.cnJul 2 04:33 ET